Skip to main content
Year archive

Sihuan Pharmaceutical Holdings Group Ltd. — 2022 filings

All 73 regulatory filings released by Sihuan Pharmaceutical Holdings Group Ltd. (460) in 2022, sourced directly from the official regulator.

73 Filings
2022 Period
2022 filings (73)
Filing Released Lang
Remuneration Committee Terms of Reference Adopted by the Board on 8 October 2010 and Amended by the Board on 19 March 2012 and 17 December 2022
Remuneration Information
2022-12-19 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022
Regulatory Filings
2022-12-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022
Share Issue/Capital Change
2022-11-01 English
ADOPTION OF THE 2022 SHARE AWARD SCHEME AND SUPPLEMENTAL INFORMATION IN RELATION TO THE 2021 ANNUAL REPORT
Regulatory Filings
2022-10-26 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2022-10-17 English
CHANGE OF EXECUTIVE DIRECTOR, JOINT COMPANY SECRETARY AND PROCESS AGENT
Board/Management Information
2022-10-14 English
DISCLOSEABLE AND CONNECTED TRANSACTIONS DISPOSAL OF EQUITY INTERESTS IN TWO SUBSIDIARIES
Capital/Financing Update
2022-10-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022
Regulatory Filings
2022-10-03 English
UPDATE ON THE PROGRESS OF THE PROPOSED SPIN-OFF OF XUANZHU BIOPHARMACEUTICAL FOR INDEPENDENT LISTING ON THE SHANGHAI STOCK EXCHANGE
Capital/Financing Update
2022-09-27 English
Notification Letter and Request Form to Non-registered Holder
Report Publication Announcement
2022-09-23 English
Notification Letter and Change Request Form to Registered Shareholder
Report Publication Announcement
2022-09-23 English
Interim Report 2022
Interim / Quarterly Report H1 2022
2022-09-23 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022
Regulatory Filings
2022-09-02 English
Special Cash Dividend for the six months ended 30 June 2022
Notice of Dividend Amount
2022-08-30 English
Interim Cash Dividend for the six months ended 30 June 2022
Notice of Dividend Amount
2022-08-30 English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2022
Interim / Quarterly Report H1 2022
2022-08-30 English
NOTICE OF BOARD MEETING
Regulatory Filings
2022-08-18 English
VOLUNTARY ANNOUNCEMENT-ADJUSTMENT OF ORGANIZATIONAL STRUCTURE
Board/Management Information
2022-08-16 English
PROFIT WARNING
Regulatory Filings
2022-08-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2022
Share Issue/Capital Change
2022-08-02 English
VOLUNTARY ANNOUNCEMENT-APPLICATION FOR MARKETING OF XUANZHU BIOPHARM'S DRUG FULVESTRANT INJECTION ACCEPTED BY NMPA
Regulatory Filings
2022-07-27 English
CHANGE OF ADDRESS OF HONG KONG BRANCH SHARE REGISTRAR AND TRANSFER OFFICE
Regulatory Filings
2022-07-22 English
VOLUNTARY ANNOUNCEMENT-FIVE PRODUCTS INCLUDING OCTREOTIDE ACETATE INJECTION WON THE BID OF THE SEVENTH BATCH OF NATIONAL CENTRALIZED DRUG PROCUREMENT
Regulatory Filings
2022-07-21 English
VOLUNTARY ANNOUNCEMENT-XUANZHU BIOPHARM OBTAINED NMPA APPROVAL FOR CONDUCTING PHASE II CLINICAL TRIALS ON NEW INDICATION OF INDEPENDENTLY DEVELOPED DRUG ANAPRAZOLE SODIUM
Regulatory Filings
2022-07-19 English
VOLUNTARY ANNOUNCEMENT-THE NDA OF INSULIN DEGLUDEC INJECTION,THE NEW GENERATION OF INSULIN ANALOGUE DEVELOPED BY HUISHENG BIOPHARMACEUTICAL, ACCEPTED BY NMPA
Regulatory Filings
2022-07-18 English
PROPOSED DISPOSAL OF PART OF THE BUSINESS AND ASSETS
Capital/Financing Update
2022-07-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022
Share Issue/Capital Change
2022-07-05 English
VOLUNTARY ANNOUNCEMENT - XUANZHU BIOPHARM ENTERED INTO AN EXCLUSIVE LICENSING AGREEMENT WITH NEW ASIA PHARMACEUTICAL FOR THE DEVELOPMENT AND COMMERCIALIZATION OF BENAPENEM AND PLAZOMINCIN IN THE GREAT
Capital/Financing Update
2022-06-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022
Regulatory Filings
2022-06-06 English
VOLUNTARY ANNOUNCEMENT-SIHUAN PHARMACEUTICAL'S SUBSIDIARY JILIN HUISHENG BIOPHARMACEUTICAL CO., LTD. COMPLETED ROUND A FINANCING SUCCESSFULLY
Capital/Financing Update
2022-06-01 English
VOLUNTARY ANNOUNCEMENT-XUANZHU BIOPHARM ENTERS INTO THE COOPERATIVE AGREEMENT IN RELATION TO COMBINATION THERAPIES WITH CTTQ-AKESO (SHANGHAI) BIOMED. TECH. CO., LTD.
Regulatory Filings
2022-05-30 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2021
Environmental & Social Information
2022-05-27 English
VOLUNTARY ANNOUNCEMENT-XZB-0004, A DRUG DEVELOPED IN COLLABORATION BETWEEN XUANZHU BIOPHARM AND SIGNALCHEM, OBTAINED APPROVAL FOR CLINICAL TRIAL IN ADVANCED SOLID TUMORS AND HEMATOLOGICAL MALIGNANCIES
Regulatory Filings
2022-05-26 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 24 MAY 2022 AND DIVIDEND PAYMENT
Declaration of Voting Results & Voting Rights Announcements
2022-05-24 English
VOLUNTARY ANNOUNCEMENT-CLARIFICATION REGARDING CERTAIN MEDIA REPORTS
Regulatory Filings
2022-05-12 English
PROPOSED DEEMED DISPOSAL AND MAJOR TRANSACTION IN RELATION TO THE PROPOSED SPIN-OFF AND SEPARATE LISTING OF XUANZHU BIOPHARMACEUTICAL TECHNOLOGY
Regulatory Filings
2022-05-04 English
Notification Letter and Request Form to Non-registered Holder
Report Publication Announcement
2022-05-04 English
Notification Letter and Change Request Form to Registered Shareholder
Report Publication Announcement
2022-05-04 English
PROPOSED DEEMED DISPOSAL AND MAJOR TRANSACTION IN RELATION TO THE PROPOSED SPIN-OFF AND SEPARATE LISTING OF XUANZHU BIOPHARMACEUTICAL TECHNOLOGY
Proxy Solicitation & Information Statement
2022-05-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022
Share Issue/Capital Change
2022-05-03 English
Notification Letter and Request Form to Non-registered Holder
Report Publication Announcement
2022-04-19 English
Notification Letter and Change Request Form to Registered Shareholder
Report Publication Announcement
2022-04-19 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
AGM Information
2022-04-19 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2022-04-19 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, DECLARATION AND PAYMENT OF A FINAL CASH DIVIDEND AND A SPECIAL CASH DIVIDEND, RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF
AGM Information
2022-04-19 English
Annual Report 2021
Annual Report FY 2021
2022-04-19 English
DISCLOSEABLE TRANSACTION - DISPOSAL OF EQUITY INTERESTS IN BEIJING XUANSHENG PHARMACEUTICAL CO., LTD.
Capital/Financing Update
2022-04-18 English
VOLUNTARY ANNOUNCEMENT - SIHUAN PHARMACEUTICAL OBTAINED CLASS III MEDICAL DEVICE REGISTRATION CERTIFICATE FROM NMPA FOR EXCLUSIVELY DISTRIBUTED HYALURONIC ACID PERSNICA
Regulatory Filings
2022-04-18 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022
Regulatory Filings
2022-04-04 English
Special Cash Dividend for the year ended 31 December 2021
Notice of Dividend Amount
2022-03-29 English
Final Cash Dividend for the year ended 31 December 2021
Notice of Dividend Amount
2022-03-29 English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021
Annual Report FY 2021
2022-03-29 English
PROPOSED SPIN-OFF OF XUANZHU BIOPHARMACEUTICAL TECHNOLOGY CO., LTD. FOR INDEPENDENT LISTING ON THE STAR MARKET OF THE SHANGHAI STOCK EXCHANGE
Capital/Financing Update
2022-03-27 English
NOTICE OF BOARD MEETING
Regulatory Filings
2022-03-17 English
VOLUNTARY ANNOUNCEMENT-SIHUAN PHAMACEUTICAL ACQUIRED SHENZHEN YIMEI TO EXPAND IN OPTOELECTRONIC DEVICE FIELD
Capital/Financing Update
2022-03-14 English
VOLUNTARY ANNOUNCEMENT-SIHUAN PHARMACEUTICAL'S FIRST CLASS 1 MACROMOLECULE INNOVATIVE DRUG HER2 BISPECIFIC ANTIBODY XZP-KM257 WAS APPROVED FOR CLINICAL TRIALS
Regulatory Filings
2022-03-08 English
VOLUNTARY ANNOUNCEMENT-SIHUAN PHARMACEUTICAL REACHED EXCLUSIVE DISTRIBUTION AGREEMENT IN RELATION TO CELLBOOSTER WITH SWISS SUISSELLE
Regulatory Filings
2022-03-07 English
VOLUNTARY ANNOUNCEMENT-GYNECOLOGICAL DRESSING PRODUCTS OBTAINED MEDICAL DEVICE REGISTRATION CERTIFICATE
Regulatory Filings
2022-03-07 English
VOLUNTARY ANNOUNCEMENT-MEDICAL DEVICE REGISTRATION CERTIFICATE OBTAINED FOR FOUR MEDICAL SKIN CARE DRESSING PATCH PRODUCTS
Regulatory Filings
2022-03-02 English
VOLUNTARY ANNOUNCEMENT-NEW DRUG APPLICATION OF SIHUAN PHARMACEUTICAL'S FIRST SELF-DEVELOPED ANTI-DIABETIC INNOVATIVE PATENTED DRUG JANAGLIFLOZIN ACCEPTED BY NMPA
Capital/Financing Update
2022-03-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022
Regulatory Filings
2022-03-01 English
VOLUNTARY ANNOUNCEMENT - MEDICAL DEVICE REGISTRATION CERTIFICATE OBTAINED FOR THREE PRODUCTS INCLUDING RECOMBINANT TYPE III COLLAGEN GEL DRESSING
Regulatory Filings
2022-03-01 English
VOLUNTARY ANNOUNCEMENT-MEDICAL DEVICE REGISTRATION CERTIFICATE OBTAINED FOR MEDICAL SCAR REPAIR PRODUCTS
Regulatory Filings
2022-02-28 English
VOLUNTARY ANNOUNCEMENT-DRUG REGISTRATION APPROVAL GRANTED FOR TENOFOVIR ALAFENAMIDE FUMARATE TABLET
Regulatory Filings
2022-02-24 English
VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE
Regulatory Filings
2022-02-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022
Regulatory Filings
2022-02-07 English
VOLUNTARY ANNOUNCEMENT-BIOLOGICS LICENSE APPLICATION OF THREE INSULIN ASPART INJECTION PRODUCTS DEVELOPED BY SIHUAN PHARMACEUTICAL ACCEPTED BY NMPA
Regulatory Filings
2022-01-27 English
VOLUNTARY ANNOUNCEMENT-ESTABLISHMENT OF JOINT VENTURE WITH BLUEPHA CO., LTD.
Regulatory Filings
2022-01-20 English
VOLUNTARY ANNOUNCEMENT-MEDICAL DEVICE REGISTRATION CERTIFICATE OBTAINED FOR MEDICAL SKIN CARE GEL AND REPAIR GEL
Regulatory Filings
2022-01-10 English
VOLUNTARY ANNOUNCEMENT-DRUG REGISTRATION APPROVAL GRANTED FOR TICAGRELOR TABLET (60MG AND 90MG)
Regulatory Filings
2022-01-10 English
VOLUNTARY ANNOUNCEMENT-EXCLUSIVE DISTRIBUTION AGREEMENT IN RELATION TO GOLDEN MICRONEEDLE WITH VIOL KOREA
Regulatory Filings
2022-01-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2021
Regulatory Filings
2022-01-04 English
DISCLOSEABLE TRANSACTION - FUNDRAISING OF XUANZHU BIOPHARMACEUTICAL TECHNOLOGY CO., LTD.
Capital/Financing Update
2022-01-02 English